At the 11th annual Joining FORCEs Against Hereditary Cancer conference in San Diego, California, Hite discussed the treatment of lymphedema. Education plays a key role, she said: “Education needs to start early on and across disease groups that are [affected] by lymphedema.”
There are 2 types of lymphedema: primary, which is less common and arises from developmental abnormalities of the lymphatic system, and secondary, the type seen in patients with cancer as it arises from trauma to the lymphatic system. Secondary lymphedema can be a result of surgery, radiation, cancer itself, obesity, or infection.
Although lymphedema is predominantly seen in patients with breast cancer—including 20% of those who undergo axillary node dissection and 15% of individuals who have a sentinel lymph node biopsy followed by radiation— it can also occur in patients with gynecological cancers (20%), melanoma (16%), genitourinary cancers (13%), and head and neck cancer (75%).
The gold standard of treatment for lymphedema includes complete decongestive therapy, which combines:
- lymph node drainage (very light pressure and long, gentle, rhythmic strokes that promote proper drainage of fluid from the lymph node.
- bandages (multilayers worn 23 hours a day, 7 days a week during active treatment)
- garments (used in the second phase, when the limb is decongested and volume changes are minimal)